NCT02863965|UnknownDMC
Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
March 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThe aim of the study is to evaluate the diagnostic value of high definition endoscopy and optic enhancement in gastric neoplasia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2016
Date type not reportedThis date has not been verified as actual or estimated.
July 30, 2016
Actual (reported)August 11, 2016
Actual (reported)October 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Sensitivity of optical enhancement endoscopy in diagnosis of gastric neoplasia
8 months
Specificity of optical enhancement endoscopy in diagnosis of gastric neoplasia
8 months
Positive predictive value of optical enhancement endoscopy in diagnosis of gastric neoplasia
8 months
Negative predictive value of optical enhancement endoscopy in diagnosis of gastric neoplasia
8 months
The inter-observer and intra-observer agreement of optic enhancement endoscopy in gastric neoplasia
8 months
All the patients underwent routine preparation before the procedure. The detected lesions in high definition endoscopy were observed with optic enhancement mode. The endoscopist was required to give the real-time descriptions of surface pit patterns of the lesions, based on surface pattern classification. After that, biopsy specimens will be obtained respectively by forceps from each detected lesion recorded for histologic diagnosis.
Patients with dyspeptic symptoms and aged 40 years or older, or with Helicobacter pylori infection, histologically verified gastric intestinal metaplasia or atrophic gastritis, or with family history of gastric cancer
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
Yanqing Li, PhD. MD.
Department of Gastroenterology, Qilu Hospital, Shandong University
First Submitted
July 30, 2016
First Posted
August 11, 2016
Study Start
March 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2016
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 11, 2016
Record last verified: 2016-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: